Found: 25
Select item for more details and to access through your institution.
Difficulties on the access to innovative targeted therapies for lung cancer in Spain.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 3, p. 597, doi. 10.1007/s12094-023-03303-5
- By:
- Publication type:
- Article
Correction to: SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022).
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022).
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 9, p. 2679, doi. 10.1007/s12094-023-03216-3
- By:
- Publication type:
- Article
Association between Changes in the Patterns of Antinuclear Autoantibodies during Immune Checkpoint Inhibition Therapy and the Development of Severe Immune Related Adverse Events.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 20, p. 12641, doi. 10.3390/ijms232012641
- By:
- Publication type:
- Article
BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01815-w
- By:
- Publication type:
- Article
Epidermolysis bullosa acquisita induced by atezolizumab.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2023, v. 21, n. 11, p. 1407, doi. 10.1111/ddg.15203
- By:
- Publication type:
- Article
Epidermolysis bullosa acquisita ausgelöst durch Atezolizumab.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2023, v. 21, n. 11, p. 1407, doi. 10.1111/ddg.15203_g
- By:
- Publication type:
- Article
The integration of systemic and tumor PD-L1 as a predictive biomarker of clinical outcomes in patients with advanced NSCLC treated with PD-(L)1blockade agents.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 1823, doi. 10.1007/s00262-021-03107-y
- By:
- Publication type:
- Article
Circulating leukocyte–platelet complexes as a predictive biomarker for the development of immune-related adverse events in advanced non-small cell lung cancer patients receiving anti-PD-(L)1 blocking agents.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 6, p. 1691, doi. 10.1007/s00262-020-02793-4
- By:
- Publication type:
- Article
Kinetics of IFNγ-Induced Cytokines and Development of Immune-Related Adverse Events in Patients Receiving PD-(L)1 Inhibitors.
- Published in:
- Cancers, 2024, v. 16, n. 9, p. 1759, doi. 10.3390/cancers16091759
- By:
- Publication type:
- Article
Usefulness of Two Independent DNA and RNA Tissue-Based Multiplex Assays for the Routine Care of Advanced NSCLC Patients.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1124, doi. 10.3390/cancers12051124
- By:
- Publication type:
- Article
Detecting ALK, ROS1, and RET fusions and the METΔex14 splicing variant in liquid biopsies of non‐small‐cell lung cancer patients using RNA‐based techniques.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 9, p. 1884, doi. 10.1002/1878-0261.13468
- By:
- Publication type:
- Article
Multiplex RNA‐based detection of clinically relevant MET alterations in advanced non‐small cell lung cancer.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 2, p. 350, doi. 10.1002/1878-0261.12861
- By:
- Publication type:
- Article
EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, p. 1, doi. 10.1038/s41698-024-00518-9
- By:
- Publication type:
- Article
ALK inhibitors in non-small cell lung cancer: the latest evidence and developments.
- Published in:
- Therapeutic Advances in Medical Oncology, 2016, v. 8, n. 1, p. 32, doi. 10.1177/1758834015617355
- By:
- Publication type:
- Article
Osimertinib in the treatment of patients with epidermal growth factor receptor T790M mutation-positive metastatic non-small cell lung cancer: clinical trial evidence and experience.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2016, v. 10, n. 6, p. 549, doi. 10.1177/1753465816670498
- By:
- Publication type:
- Article
Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform.
- Published in:
- Clinical Chemistry, 2021, v. 67, n. 3, p. 554, doi. 10.1093/clinchem/hvaa248
- By:
- Publication type:
- Article
Pharmacogenetic clinical randomised phase II trial to evaluate the efficacy and safety of FOLFIRI with high-dose irinotecan (HD-FOLFIRI) in metastatic colorectal cancer patients according to their UGT1A 1 genotype.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Regression of Late Onset Choroidal Metastasis from a Breast Carcinoma with Letrozole.
- Published in:
- Case Reports in Ophthalmology, 2011, v. 2, n. 3, p. 382, doi. 10.1159/000334937
- By:
- Publication type:
- Article
ERCC1 and ERCC2 Polymorphisms Predict the Efficacy and Toxicity of Platinum-Based Chemotherapy in Small Cell Lung Cancer.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 9, p. 1121, doi. 10.3390/pharmaceutics16091121
- By:
- Publication type:
- Article
Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain.
- Published in:
- BMC Pulmonary Medicine, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12890-023-02356-0
- By:
- Publication type:
- Article
Potential Role of Circulating PD-L1 + Leukocytes as a Predictor of Response to Anti-PD-(L)1 Therapy in NSCLC Patients.
- Published in:
- Biomedicines, 2024, v. 12, n. 5, p. 958, doi. 10.3390/biomedicines12050958
- By:
- Publication type:
- Article
Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis.
- Published in:
- Oncology & Therapy, 2022, v. 10, n. 1, p. 167, doi. 10.1007/s40487-021-00182-0
- By:
- Publication type:
- Article
Immune-Related Adverse Events and Corticosteroid Use for Cancer-Related Symptoms Are Associated With Efficacy in Patients With Non-small Cell Lung Cancer Receiving Anti-PD-(L)1 Blockade Agents.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01677
- By:
- Publication type:
- Article
SPARC gene variants predict clinical outcome in locally advanced and metastatic pancreatic cancer patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article